Journal: Digestion
Submission Deadline: December 31, 2024
Duodenal neoplasms were once considered to be very rare and, due to this rarity, their biological behavior and precise diagnostic methods have long been poorly understood compared to other tumors of the gastrointestinal tract. Additionally, endoscopic treatment for duodenal neoplasia has been known to be highly dangerous because of the duodenum's anatomical feature of being fixed to the retroperitoneum and its exposure to bile and pancreatic fluid. However, recent improvements in endoscopic equipment and increased awareness among endoscopists have led to a better understanding of the biological behavior and endoscopic diagnosis of duodenal neoplasia. Moreover, improved treatment outcomes have been achieved through the development of devices, refined treatment techniques, and the establishment of perioperative management.
This article collection, entitled “Current Management of Duodenal Neoplasia”, aims to provide a comprehensive overview of the latest advances in this rapidly growing field. The primary objective is to identify and highlight the efforts of research groups that are advancing the field of diagnosis and endoscopic management for duodenal neoplasia. Researchers are welcome to contribute their valuable insights in the form of research articles and systematic reviews.
Please select the option “Call for Papers: Duodenal neoplasia” when submitting your manuscript and mention this Call for Papers in your cover letter.
Digestion supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.
Check out the Author Guidelines.